CN220473549U - Myocardial troponin detection kit - Google Patents
Myocardial troponin detection kit Download PDFInfo
- Publication number
- CN220473549U CN220473549U CN202321126928.5U CN202321126928U CN220473549U CN 220473549 U CN220473549 U CN 220473549U CN 202321126928 U CN202321126928 U CN 202321126928U CN 220473549 U CN220473549 U CN 220473549U
- Authority
- CN
- China
- Prior art keywords
- wall
- detection
- weighing
- fixedly provided
- box
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 80
- 230000002107 myocardial effect Effects 0.000 title abstract description 9
- 238000005303 weighing Methods 0.000 claims abstract description 52
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 19
- 230000000747 cardiac effect Effects 0.000 claims description 14
- 238000003149 assay kit Methods 0.000 claims description 8
- 229920000742 Cotton Polymers 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- 239000010985 leather Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 27
- 230000000857 drug effect Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 2
- 102000004903 Troponin Human genes 0.000 description 13
- 108090001027 Troponin Proteins 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- 241001330002 Bambuseae Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 208000002251 Dissecting Aneurysm Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 102000013394 Troponin I Human genes 0.000 description 1
- 108010065729 Troponin I Proteins 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 206010002895 aortic dissection Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000037891 myocardial injury Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 206010047470 viral myocarditis Diseases 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model relates to the technical field of myocardial troponin detection, and discloses a myocardial troponin detection kit, which comprises a detection box, wherein the outer wall of the detection box is fixedly connected with a connecting structure, the outer wall of the connecting structure is fixedly connected with a box cover, the inner cavity of the detection box is fixedly provided with a detection platform, the outer wall of the detection platform is fixedly provided with a placement part, the inner cavity of the placement part is provided with a weighing cylinder, the outer wall of the detection platform is fixedly provided with a weighing hole, and the detection device on the device, a display, a weighing sensor and reagent paper are mutually matched, so that the detection device on the device can be used for directly detecting whether the drug effect is effective or not, the drug dosage can be controlled and understood under the cooperation of the weighing sensor and the display, and the detection result of the drug is further determined by adopting an alternative scheme reagent paper if necessary, thereby enhancing the detection accuracy.
Description
Technical Field
The utility model relates to the technical field of detection of cardiac troponin, in particular to a cardiac troponin detection kit.
Background
The cardiac troponin is mainly used for examining myocardial injury or necrosis related diseases such as myocardial infarction, viral myocarditis, acute heart failure, renal failure, and myocardial anoxia diseases such as severe sepsis and septic shock, aortic dissection, pulmonary embolism, etc. In screening the above diseases, the cardiac troponin assay kit is used to quantitatively determine the amount of human serum, plasma or whole blood center troponin I in vitro.
The myocardial troponin detection kit can be put into normal use only by detecting, observing, verifying, accurately extracting and taking the detection reagent during detection, and the existing myocardial troponin detection kit lacks corresponding design in the aspects of detecting and accurately extracting the reagent, so that a plurality of instruments are required to be matched for common use.
Disclosure of Invention
Aiming at the defects of the prior art, the utility model provides a myocardial troponin detection kit, which has the following technical scheme: a cardiac troponin assay kit comprising:
the detection box and the connecting structure arranged on the detection box;
the outer wall of the connecting structure is fixedly connected with a box cover;
the inner cavity of the detection box is fixedly provided with a detection platform;
the outer wall of the detection platform is fixedly provided with a placement position;
a weighing cylinder is arranged in the inner cavity of the placement part;
the outer wall of the detection platform is fixedly provided with a weighing hole;
the inner wall of the weighing hole is fixedly provided with a weighing sensor;
the outer wall of the detection platform is fixedly provided with a display;
the outer wall of the detection platform is fixedly provided with a detection device;
the inner wall of the box cover is fixedly provided with a placing rack;
a rubber head dropper is arranged on the outer wall of the placing frame;
a pipettor is arranged on the outer wall of the placing rack;
the outer wall of rack has placed the test tube.
In the preferred scheme, the fixed dose scale that is equipped with of outer wall of a weighing section of thick bamboo, the outer wall of a weighing section of thick bamboo has cup jointed the skin stopper.
In a preferred scheme, a cotton layer is placed in the inner cavity of the detection box.
In a preferred scheme, reagent paper is placed on the outer wall of the detection platform.
In a preferred scheme, a thermometer is fixedly arranged on the inner wall of the box cover;
in a preferred embodiment, the inner wall of the case cover is fixedly equipped with a contrast color card.
Compared with the prior art, the utility model has the following beneficial effects:
according to the myocardial troponin detection kit, the medicament is detected through the mutual matching of the detection device, the display, the weighing sensor and the reagent paper on the device, the medicament dosage is controlled and known under the matching of the weighing sensor and the display, and the detection result of the medicament is further determined by adopting the reagent paper with an alternative scheme when necessary, so that the detection accuracy is enhanced, and the detection result accuracy is ensured.
Drawings
FIG. 1 is a schematic perspective view of the present utility model;
FIG. 2 is a schematic diagram of the structure of the detecting device of the present utility model;
FIG. 3 is an enlarged schematic view of the structure A in FIG. 2 according to the present utility model;
FIG. 4 is an enlarged schematic view of the structure of FIG. 2B according to the present utility model;
fig. 5 is a schematic view of the weighing cylinder structure of the utility model.
In the figure: 1. a detection box; 2. a connection structure; 3. a case cover; 4. a detection platform; 5. placing; 6. a weighing cylinder; 601. dose graduations; 602. a leather plug; 7. a weighing hole; 8. a weighing sensor; 9. a display; 10. a detection device; 11. reagent paper; 12. a placing rack; 13. a rubber head dropper; 14. a pipette; 15. a test tube; 16. a thermometer; 17. a contrast color card; 18. cotton layer.
Detailed Description
The following description of the embodiments of the present utility model will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present utility model, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the utility model without making any inventive effort, are intended to be within the scope of the utility model.
Referring to fig. 1-5, a cardiac troponin detection kit includes a detection box 1, a connection structure 2 fixedly connected to an outer wall of the detection box 1, a box cover 3 fixedly connected to an outer wall of the connection structure 2, a detection platform 4 fixedly mounted to an inner cavity of the detection box 1, a placement 5 fixedly mounted to an outer wall of the detection platform 4, a weighing cylinder 6 mounted to an inner cavity of the placement 5, a weighing hole 7 fixedly mounted to an outer wall of the detection platform 4, a weighing sensor 8 fixedly mounted to an inner wall of the weighing hole 7, a display 9 fixedly mounted to an outer wall of the detection platform 4, a detection device 10 fixedly mounted to an outer wall of the detection platform 4, a reagent paper 11 mounted to an outer wall of the detection platform 4, a rack 12 fixedly mounted to an inner wall of the box cover 3, a rubber head dropper 13 mounted to an outer wall of the rack 12, a liquid transferring device 14 mounted to an outer wall of the rack 12, a test tube 15 mounted to an outer wall of the rack 12, the thermometer 16 is fixedly arranged on the inner wall of the box cover 3, the contrast color card 17 is fixedly arranged on the inner wall of the box cover 3, the cotton layer 18 is arranged in the inner cavity of the detection box 1, and the weighing holes 7, the weighing sensors 8 and the display 9 are matched for use, so that when the device is used for detecting the medicament, different weighing cylinders 6 can be selectively used for weighing the medicaments with different dosages, accurately knowing the input quantity, knowing whether the medicaments are in normal weight values, and knowing the control of the intake dosage of a patient and knowing whether the medicaments are in normal weight values, and the detection device 10, the display 9, the weighing sensors 8 and the reagent paper 11 on the device can directly detect whether the medicament effect is effective or not by the detection device 10 on the device, and under the cooperation of the weighing sensor 8 and the display 9, the dosage of the medicament is controlled and known, and the detection result of the medicament is further determined by adopting the alternative scheme reagent paper 11 when necessary, so that the detection accuracy is enhanced, and the detection result is ensured to be accurate.
Referring to fig. 4, a dose scale 601 is fixed on the outer wall of the weighing cylinder 6, a plug 602 is sleeved on the outer wall of the weighing cylinder 6, and a worker can put the detected medicament into the weighing cylinder 6 by opening the plug 602 and observing the specific gravity of the put medicament by using the dose scale 601 through the plug 602 and the dose scale 601 arranged on the device, so that the detected dose is accurately controlled.
Referring to fig. 2-5, the placement portion 5 is matched with the weighing hole 7, and through the mutual matching of the placement portion 5 and the weighing hole 7, the weighing cylinder 6 on the device is stored in the inner cavity of the placement portion 5 when not in use, and is placed in the inner cavity of the weighing hole 7 for weighing when in use, so that convenience is provided for dual environments when in leisure and when in need.
Referring to fig. 2, the weighing sensor 8 is electrically connected to the display 9, and after a certain amount of medicament is injected into the weighing cylinder 6 on the device, the weighing sensor 8 fixedly assembled in the inner cavity of the weighing hole 7 is used for weighing the medicament, and weight information is fed back to the display 9, so that the weighing information feedback of a plurality of weighing cylinders 6 is known.
Referring to fig. 2, the reagent paper 11 is an alternative scheme of detecting a reagent kit, and the reagent paper 11 is used to prepare a detection scheme for detecting a reagent by using the reagent paper 11 when further verification is required or data is not ideal after the drug effect detection is performed by the detection device 10 on the device.
Referring to fig. 1, a thermometer 16 and a contrast color chart 17 provide a convenient observation method for detecting cardiac troponin, so that when the device detects cardiac troponin, the detection environment needs to be kept between 20 ℃ and 25 ℃ through the thermometer 16 and the contrast color chart 17 on the device, the temperature of the detection environment is known through the thermometer 16 on the device, the color formation of the detection medicament is known through the contrast color chart 17, and therefore the detection environment is known, and the contrast is created for the detected color formation of the medicament.
When the device is used, firstly, through the matching use of the weighing hole 7, the weighing sensor 8 and the display 9 on the device, the device can selectively use different weighing barrels 6 to weigh different doses of medicaments when detecting the medicaments, accurately know the amount required to be input and know whether the medicaments are in normal weight values, so as to realize the control of taking the doses by patients and the understanding of whether the medicaments are in normal weight values, and then, through the matching of the detection device 10, the display 9, the weighing sensor 8 and the reagent paper 11 on the device, the detection device 10 on the device can directly detect whether the medicament effect is effective or not, and under the matching of the weighing sensor 8 and the display 9, the medicament doses are controlled and known, and the detection result of the medicaments is further determined by adopting the alternative scheme reagent paper 11 when necessary, thereby enhancing the detection accuracy, ensuring the detection result accuracy, and using the contrast color card 17 to know the color of the detected medicaments and comparing the color of the detected medicaments.
Although embodiments of the present utility model have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made therein without departing from the principles and spirit of the utility model, the scope of which is defined in the appended claims and their equivalents.
Claims (6)
1. A cardiac troponin assay kit, comprising:
the detection box (1) and the connecting structure (2) arranged on the detection box (1);
the outer wall of the connecting structure (2) is fixedly connected with a box cover (3);
the inner cavity of the detection box (1) is fixedly provided with a detection platform (4);
the outer wall of the detection platform (4) is fixedly provided with a placement part (5);
a weighing cylinder (6) is arranged in the inner cavity of the placement part (5);
a weighing hole (7) is fixedly formed in the outer wall of the detection platform (4);
the inner wall of the weighing hole (7) is fixedly provided with a weighing sensor (8);
the outer wall of the detection platform (4) is fixedly provided with a display (9);
the outer wall of the detection platform (4) is fixedly provided with a detection device (10);
the inner wall of the box cover (3) is fixedly provided with a placing rack (12);
a rubber head dropper (13) is arranged on the outer wall of the placing frame (12);
a pipettor (14) is arranged on the outer wall of the placing rack (12);
the outer wall of the placing frame (12) is provided with a test tube (15).
2. A cardiac troponin assay kit according to claim 1, wherein: the outer wall of the weighing cylinder (6) is fixedly provided with a dose scale (601), and the outer wall of the weighing cylinder (6) is sleeved with a leather plug (602).
3. A cardiac troponin assay kit according to claim 1, wherein: the inner cavity of the detection box (1) is provided with a cotton layer (18).
4. A cardiac troponin assay kit according to claim 1, wherein: the outer wall of the detection platform (4) is provided with reagent paper (11).
5. A cardiac troponin assay kit according to claim 1, wherein: the inner wall of the case cover (3) is fixedly provided with a thermometer (16).
6. A cardiac troponin assay kit according to claim 1, wherein: the inner wall of the box cover (3) is fixedly provided with a contrast color card (17).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202321126928.5U CN220473549U (en) | 2023-05-11 | 2023-05-11 | Myocardial troponin detection kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202321126928.5U CN220473549U (en) | 2023-05-11 | 2023-05-11 | Myocardial troponin detection kit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN220473549U true CN220473549U (en) | 2024-02-09 |
Family
ID=89800324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202321126928.5U Active CN220473549U (en) | 2023-05-11 | 2023-05-11 | Myocardial troponin detection kit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN220473549U (en) |
-
2023
- 2023-05-11 CN CN202321126928.5U patent/CN220473549U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210396740A1 (en) | Methods of hematocrit correction as well as glucose meters and systems adapted therefor | |
| US20200232983A1 (en) | System and method for detecting a periprosthetic infection | |
| WO2012084234A1 (en) | Storage of calibration data at a continuous glucose monitor | |
| CN220473549U (en) | Myocardial troponin detection kit | |
| CN100580447C (en) | Method for determining human plasma antiviral drug concentration | |
| CN103439517A (en) | Systemic lupus erythematosus (SLE) autoantibody detector | |
| CN108133754A (en) | The forecasting system of bleeding risk after a kind of thrombolysis | |
| CN108048525A (en) | The kit of bleeding risk after a kind of detection thrombolysis | |
| WO2019115725A1 (en) | Preparation device, diagnostic apparatus, diagnostic kit and diagnostic system | |
| Pierce et al. | Development of a point-of-contact technique to measure adenosine triphosphate: A quality improvement study | |
| CN108742551A (en) | A kind of pocket imitates Chinese medicine and takes arteries and veins device automatically | |
| CN106066396A (en) | A kind of kit being easy to Analysis of Biochemical | |
| CN210802651U (en) | Device of intelligent food intake monitoring electronic scale | |
| JPH07503538A (en) | Measuring fluid properties | |
| JPH01155267A (en) | Executing method of separation and collection of urine and weighing inspection thereof | |
| CN206214477U (en) | A kind of medical urine volume graduated cylinder | |
| Jähne-Raden et al. | Trodden Lanes or New Paths: Ballisto-and Seismocardiography Till Now. | |
| CN208404566U (en) | A kind of constitution scale with cardiovascular detection function | |
| CN105973825B (en) | A kind of whole blood biochemistry detection method and device | |
| CN205679616U (en) | A kind of Immunofluorescence test instrument for acute myocardial infarction detection | |
| Klein et al. | Accuracy and precision of the portable StatPal II and the laboratory‐based NOVA Stat Profile 1 for measurement of pH, PCO2, and PO2 in equine blood | |
| CN209247788U (en) | A kind of gold label test strip detection assisted reaction cup | |
| CN110013238A (en) | Multifunctional chair for health detection | |
| KR100855605B1 (en) | A system for prediction and diagnosis of metabolic syndrome | |
| Nakae et al. | Detection of metabolic abnormality in asynergic regions of ischemic human myocardium using 31P and 1H magnetic resonance spectroscopy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240402 Address after: No. 210, 2nd Floor, Standard Building 4, Jinkai Industrial Park, No. 19 East Guokai Avenue, Nanning City, Guangxi Zhuang Autonomous Region, 530031 Patentee after: Guangxi Ainei Diagnostic Technology Co.,Ltd. Country or region after: China Address before: Room 401, 4th Floor, Building 2, Qingdao Blue Biopharmaceutical Industrial Park, No. 368 Hedong Road, High tech Industrial Development Zone, Qingdao City, Shandong Province, 266000 Patentee before: Baditai (Qingdao) Biotechnology Co.,Ltd. Country or region before: China |
|
| TR01 | Transfer of patent right |